Dilipkumar Pal

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 9

Top Topics

Prostate Cancer

Oxidative Stress

Silver Nanoparticles

Top Venues

BioMed research international

This page only lists publications with an associated author ORCID identifier.

Publications

Dilipkumar Pal, Khushboo Raj, Shyam Sundar Nandi, Surajit Sinha, Abhishek Mishra, Arijit Mondal, Ricardo Lagoa, Jack T Burcher, Anupam Bishyaee
Potential of Synthetic and Natural Compounds as Novel Histone Deacetylase Inhibitors for the Treatment of Hematological Malignancies. Cancers 15 (10) (2023)
Dilipkumar Pal, Padum Lal
Tropolones and Thailandepsin B as lead-like natural compounds in the development of potent and selective histone deacetylase inhibitors. Current drug targets (2023)
Dilipkumar Pal, Pooja Sahu, Gautam Sethi, Carly E Wallace, Anupam Bishyaee
Gossypol and Its Natural Derivatives: Multitargeted Phytochemicals as Potential Drug Candidates for Oncologic Diseases. Pharmaceutics 14 (12) (2022)
Supriyo Saha, Gyu Seong Yeom, Satish Balasaheb Nimse, Dilipkumar Pal
Combination Therapy of Ledipasvir and Itraconazole in the Treatment of COVID-19 Patients Coinfected with Black Fungus: An In Silico Statement. BioMed research international 2022 (2022)
Dilipkumar Pal, Pooja Sahu, Gautam Sethi, Carly E Wallace, Anupam Bishyaee
Gossypol and Its Natural Derivatives: Multitargeted Phytochemicals as Potential Drug Candidates for Oncologic Diseases. Pharmaceutics 14 (12) (2022)
Dilipkumar Pal, Pooja Sahu, Gautam Sethi, Carly E Wallace, Anupam Bishyaee
Gossypol and Its Natural Derivatives: Multitargeted Phytochemicals as Potential Drug Candidates for Oncologic Diseases. Pharmaceutics 14 (12) (2022)
Dilipkumar Pal, Pooja Sahu, Gautam Sethi, Carly E Wallace, Anupam Bishyaee
Gossypol and Its Natural Derivatives: Multitargeted Phytochemicals as Potential Drug Candidates for Oncologic Diseases. Pharmaceutics 14 (12) (2022)
Vinod Kumar Gurjar, Dilipkumar Pal
Design, in silico studies, and synthesis of new 1,8-naphthyridine-3-carboxylic acid analogues and evaluation of their H1R antagonism effects. RSC advances 10 (23) (2020)
Dilipkumar Pal, Supriyo Saha
Chondroitin: a natural biomarker with immense biomedical applications. RSC advances 9 (48) (2019)